Epidemiology, diagnosis, and management of esophageal adenocarcinoma

JH Rubenstein, NJ Shaheen - Gastroenterology, 2015 - Elsevier
Esophageal adenocarcinoma (EAC) is rapidly increasing in incidence in Western cultures.
Barrett's esophagus is the presumed precursor lesion for this cancer. Several other risk …

Guidelines for surgical treatment of gastroesophageal reflux disease

D Stefanidis, WW Hope, GP Kohn, PR Reardon… - Surgical …, 2010 - Springer
Guidelines for surgical treatment of gastroesophageal reflux disease | SpringerLink Skip to
main content Advertisement SpringerLink Log in Menu Find a journal Publish with us Search …

British Society of Gastroenterology guidelines on the diagnosis and management of Barrett's oesophagus

RC Fitzgerald, M Di Pietro, K Ragunath, Y Ang… - Gut, 2014 - gut.bmj.com
These guidelines provide a practical and evidence-based resource for the management of
patients with Barrett's oesophagus and related early neoplasia. The Appraisal of Guidelines …

Radiofrequency ablation vs endoscopic surveillance for patients with Barrett esophagus and low-grade dysplasia: a randomized clinical trial

KN Phoa, FGI Van Vilsteren, BLAM Weusten… - Jama, 2014 - jamanetwork.com
Importance Barrett esophagus containing low-grade dysplasia is associated with an
increased risk of developing esophageal adenocarcinoma, a cancer with a rapidly …

Long-term efficacy and safety of endoscopic resection for patients with mucosal adenocarcinoma of the esophagus

O Pech, A May, H Manner, A Behrens, J Pohl… - Gastroenterology, 2014 - Elsevier
Background & Aims Barrett's esophagus–associated high-grade dysplasia is commonly
treated by endoscopy. However, most guidelines offer no recommendations for endoscopic …

American Gastroenterological Association technical review on the management of Barrett's esophagus

SJ Spechler, P Sharma, RF Souza, JM Inadomi… - …, 2011 - gastrojournal.org
The aim of evidence-based medicine is to improve the quality of health care by integrating
the best research evidence with clinical expertise and patient values. Evidence-based …

A randomised trial of endoscopic submucosal dissection versus endoscopic mucosal resection for early Barrett's neoplasia

G Terheggen, EM Horn, M Vieth, H Gabbert, M Enderle… - Gut, 2017 - gut.bmj.com
Background For endoscopic resection of early GI neoplasia, endoscopic submucosal
dissection (ESD) achieves higher rates of complete resection (R0) than endoscopic mucosal …

Durability of radiofrequency ablation in Barrett's esophagus with dysplasia

NJ Shaheen, BF Overholt, RE Sampliner, HC Wolfsen… - Gastroenterology, 2011 - Elsevier
BACKGROUND & AIMS: Radiofrequency ablation (RFA) can eradicate dysplasia and
intestinal metaplasia in patients with dysplastic Barrett's esophagus (BE), and reduce rates …

Multimodality endoscopic eradication for neoplastic Barrett oesophagus: results of an European multicentre study (EURO-II)

KN Phoa, RE Pouw, R Bisschops, O Pech, K Ragunath… - Gut, 2016 - gut.bmj.com
Objective Focal endoscopic resection (ER) followed by radiofrequency ablation (RFA) safely
and effectively eradicates Barrett's oesophagus (BO) containing high-grade dysplasia (HGD) …

Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process

C Bennett, N Vakil, J Bergman, R Harrison, R Odze… - Gastroenterology, 2012 - Elsevier
BACKGROUND & AIMS: Esophageal adenocarcinoma (EA) is increasingly common among
patients with Barrett's esophagus (BE). We aimed to provide consensus recommendations …